Evia Bio: Funding, Investors & Team (Oct 2026)
Evia Bio™ is a life science innovation company enabling the growing cell therapy market. We provide new non-DMSO cryopreservation solutions developed by world-leading cryobiologist, Allison Hubel, PhD. We partner with cell therapy companies looking to advance their products to clinical trials and commercialization. Our solutions unlock the full potential of emerging life-saving therapies through the use of all-natural organic compounds to protect the integrity of cells during cryopreservation and patient safety at the point of care. Please visit www.eviabio.com.
Evia Bio has raised $10k across 1 funding round on record, the most recent an undisclosed round of $10k announced in Dec 2022.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Evia Bio Company Profile and Key Stats
Latest funding round on record: Dec 2022.
Evia Bio Funding Rounds
Evia Bio Founders and Leadership Team
Contact details for the Evia Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Evia Bio Funding Compared to Other Biotechnology Startups
Evia Bio's latest round of $10k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evia Bio in Biotechnology and Minneapolis
Companies Similar to Evia Bio
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Evia Bio Funding FAQs
What does Evia Bio do?
Evia Bio™ is a life science innovation company enabling the growing cell therapy market. We provide new non-DMSO cryopreservation solutions developed by world-leading cryobiologist, Allison Hubel, PhD. We partner with cell therapy companies looking to advance their products to clinical trials and commercialization. Our solutions unlock the full potential of emerging life-saving therapies through the use of all-natural organic compounds to protect the integrity of cells during cryopreservation and patient safety at the point of care. Please visit www.eviabio.com.
How much funding has Evia Bio raised?
Evia Bio has raised $10k across 1 round on record. The most recent is an undisclosed round of $10k announced in Dec 2022.
When did Evia Bio last raise funding?
Evia Bio's most recent funding round on record is an undisclosed round of $10k, announced in Dec 2022.
Who founded Evia Bio?
FundedIQ lists Allison Hubel (Founder) at Evia Bio.
Where is Evia Bio headquartered?
Evia Bio is based in Minneapolis, Minnesota, United States.
How many employees does Evia Bio have?
Evia Bio is in the 1-10 employee band.
How does Evia Bio's funding compare to other Biotechnology startups?
Evia Bio's latest round of $10k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Evia Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evia Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.